Effects of pirenoxine: Using an in vitro and in vivo cataract animal model as assay systems
碩士 === 臺北醫學大學 === 藥學研究所 === 96 === Pirenoxine (Catalin®; Px) was first introduced in 1958 in Japan as an anti-cataractogenic agent. In spite of insufficient evidence, it is still widely used for cataract treatment in Taiwan now. To elucidate the pharmacology and effects of Px, in vitro and in vivo c...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/64837793119251829761 |